CCRB Logo

Modification History

CUHK_CCT00272

A randomized controlled trial of intravitreal bevacizumab monotherapy versus triple therapy with half fluence verteporfin photodynamic therapy and intravitreal bevacizumab and triamcinolone acetonide for the treatment of neovascular age-related macular degeneration

2010-11-30

Update Date Recruitment Status Modified By  
2014-05-07 Complete Registry User Detail
2013-04-30 Suspended Registry User Detail
2012-07-13 Complete Registry User Detail
2011-06-20 Complete Registry User Detail
2011-03-21 Recruiting Registry User Detail
2011-02-08 Recruiting Administrator Detail
2010-11-30 Recruiting Registry User Detail
Back